Case Series: Low-Dose Naltrexone for Chronic Fatigue Syndrome
The use of low-dose naltrexone (LDN) to treat chronic fatigue syndrome was described in a recent case series published in BMJ Case Reports.
Cassandra Pardini, PharmD
Contributing Writer
Cassandra Pardini is a freelance writer and registered pharmacist with a diverse background in drug therapy, scientific research, and the drug discovery and developmental process. She obtained her Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences University, Master of Science degree in chemistry and chemical biology from Northeastern University, and Bachelor of Science degree in chemistry from Boston College. She currently lives in Rhode Island with her husband and 3 children.
